Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate N-succinimidyl ester (AC212)
Cat.#: ASSD-212
Specifications
Description 5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate N-succinimidyl ester, an amine-reactive fluorescent tracer, is used for cell imaging and live cell tracking. It is initially colorless and non-fluorescent, but upon hydrolysis by intracellular esterases it expresses bright green fluoresence. Cell-permeable dye. Used for detecting intracellular reactive oxygen species (ROS).
toxicity, and suitability for various applications.Size 25 mg Molecule Weight 626.36 Molecular formula C29H17Cl2NO11 CAS Number 147265-60-9 MDL Number MFCD00037456 Solubility Soluble in DMSO, DMF, and methanol. Storage Store at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-224 Antifade Fluorescence Mounting Medium with DAPI (aqueous) (AC224) 10 mL inquiry ASSD-216 K 114 (AC216) 10 mg, 50 mg inquiry ASSD-161 Methylene Blue (AC161) 50 mg, 1 g inquiry ASSD-178 5-(Iodoacetamido)fluorescein (AC178) 25 mg, 100 mg, 250 mg inquiry ASSD-145 Oxazole Yellow Iodide 1mM solution (in 1mL DMSO) (AC145) 1 mL inquiry ASSD-154 Brilliant Blue R-250 (AC154) 1g, 5g inquiry ASSD-167 Fura-2 AM (Cell permeant) (AC167) 1 mg inquiry ASSD-219 Tetramethylrhodamine-6-maleimide (AC219) 5 mg inquiry ASSD-121 Fluorescent adenosine A3 antagonist [XAC] (AC121) 500 μg inquiry ASSD-156 Crystal Violet (AC156) 1g, 5g inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket